tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger

Story Highlights
Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Vigil Neuroscience Inc ( (VIGL) ) has shared an announcement.

On May 21, 2025, Vigil Neuroscience, Inc. entered into a merger agreement with Sanofi, where Vigil will become a wholly-owned subsidiary of Sanofi. The merger’s completion is contingent upon several conditions, including stockholder approval at a virtual meeting on August 4, 2025, following the expiration of the HSR Waiting Period on July 16, 2025.

The most recent analyst rating on (VIGL) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Vigil Neuroscience Inc stock, see the VIGL Stock Forecast page.

Spark’s Take on VIGL Stock

According to Spark, TipRanks’ AI Analyst, VIGL is a Underperform.

Vigil Neuroscience Inc’s stock score is primarily affected by its weak financial performance, characterized by no revenue generation and negative cash flows. The technical analysis shows some short-term positive momentum, but valuation concerns and the overbought condition suggest caution. The lack of earnings call and corporate events data means these factors did not influence the score.

To see Spark’s full report on VIGL stock, click here.

More about Vigil Neuroscience Inc

Vigil Neuroscience, Inc. is a Delaware-based company operating in the biotechnology industry, focusing on developing treatments for neurodegenerative diseases.

Average Trading Volume: 1,427,091

Technical Sentiment Signal: Buy

Current Market Cap: $384.4M

For a thorough assessment of VIGL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1